Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 978

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

The Cystine/Glutamate Antiporter System x c − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities

Open access
Lewerenz, Jan, Hewett, Sandra J., Huang, Ying, Lambros, Maria, Gout, Peter W., Kalivas, Peter W., Massie, Ann, Smolders, Ilse, Methner, Axel, Pergande, Mathias, Smith, Sylvia B., Ganapathy, Vadivel, Maher, Pamela·2013·Antioxidants & Redox Signaling
DOI 10.1089/ars.2011.4391
Open this paper in CoChat — free account

Abstract

The antiporter system xc− imports the amino acid cystine, the oxidized form of cysteine, into cells with a 1:1 counter-transport of glutamate. It is composed of a light chain, xCT, and a heavy chain, 4F2 heavy chain (4F2hc), and, thus, belongs to the family of heterodimeric amino acid transporters. Cysteine is the rate-limiting substrate for the important antioxidant glutathione (GSH) and, along with cystine, it also forms a key redox couple on its own. Glutamate is a major neurotransmitter in the central nervous system (CNS). By phylogenetic analysis, we show that system xc− is a rather evolutionarily new amino acid transport system. In addition, we summarize the current knowledge regarding the molecular mechanisms that regulate system xc−, including the transcriptional regulation of the xCT light chain, posttranscriptional mechanisms, and pharmacological inhibitors of system xc−. Moreover, the roles of system xc− in regulating GSH levels, the redox state of the extracellular cystine/cysteine redox couple, and extracellular glutamate levels are discussed. In vitro, glutamate-mediated system xc− inhibition leads to neuronal cell death, a paradigm called oxidative glutamate toxicity, which has successfully been used to identify neuroprotective compounds. In vivo, xCT has a rather restricted expression pattern with the highest levels in the CNS and parts of the immune system. System xc− is also present in the eye. Moreover, an elevated expression of xCT has been reported in cancer. We highlight the diverse roles of system xc− in the regulation of the immune response, in various aspects of cancer and in the eye and the CNS. Antioxid. Redox Signal. 18, 522–555. I. Introduction A. Oxidative stress and antioxidant defense B. GSH metabolism C. Glutamate: neurotransmission and neurotoxicity II. The Cystine/Glutamate Antiporter System xc− A. Functional and pharmacological characteristics of system xc− B. The molecular biology of system xc− C. The phylogeny of xCT, the specific subunit of system xc− D. Regulation of system xc− by transcriptional regulation of its specific subunit xCT E. Regulation of system xc− activity by protein trafficking and protein modification F. Regulation of system xc− activity by substrate availability III. Expression of System xc−In Vitro and In Vivo and Its Functional Consequences A. In the absence of disease, system xc− shows a rather restricted expression pattern in vivo B. System xc− is induced in most cultured cells C. The role of system xc− in the regulation of GSH synthesis, the extracellular redox milieu, and extracellular glutamate levels D. Oxidative glutamate toxicity—an in vitro paradigm for neuronal death induced by system xc− inhibition 1. The cell death pathway in oxidative glutamate toxicity 2. Using oxidative glutamate toxicity to identify neuroprotective pathways 3. Using oxidative glutamate toxicity to screen for neuroprotective drugs 4. Oxidative glutamate toxicity in vivo IV. The Role of System xc− in Health and Disease A. System xc−in vivo—lessons from xCT-deficient mice B. The role of system xc− in the immune system and inflammation C. The role of system xc− in cancer and resistance against anti-cancer drugs 1. System xc− is regulated by potentially oncogenic pathways 2. System xc− mediates the infection of cells by oncogenic Kaposi's sarcoma herpesvirus 3. System xc− plays an important role in the multidrug resistance of cancers 4. Inhibition of system xc− reduces cancer cell replication, tissue invasion, and metastasis 5. System xc− expressed in tumor cells may be used as a target for anticancer drug delivery 6. Up-regulation of system xc− in normal cells provides protection against carcinogenesis—a possible role in cancer prevention 7. Synopsis of the role of system xc− in cancer and resistance against anti-cancer drugs D. System xc− and diseases of the eye 1. Studies of system xc− in the retina 2. Studies of system xc− in the lens and cornea 3. Synopsis and future directions for system xc− and diseases of the eye E. The role of system xc− in diseases of the CNS F. The role of system xc− activity in memory and behavior V. Conclusion

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/ars.2011.4391

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

Metadata

Authors
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., Smith, S. B., Ganapathy, V., & Maher, P.
Venue
Antioxidants & Redox Signaling
Publisher
SAGE Publications
Published
2013-02-10
Volume
18
Issue
5
Pages
522-555
ISSN
  • 1523-0864 (ISSN-L)
  • 1557-7716
DOI
10.1089/ars.2011.4391
OpenAlex
W2000087607
Cited by
978
References
23
FWCI
8.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.